News
- Author:
- Mary Ann Moon
Publish date: August 11, 2014
Key clinical point: Catheter-directed thrombolysis carries higher risks and may not improve outcomes for proximal DVT patients.
Major finding: In-...
News
- Author:
- Mary Ann Moon
Publish date: August 6, 2014
Key clinical point: Two minimally invasive approaches to detecting misfolded prion proteins have high sensitivities and specificities for detectin...
News
- Author:
- Mary Ann Moon
Publish date: August 5, 2014
Key clinical point: Combined hormonal contraception increases the risk of VTE, especially in women with certain thrombophilic genotypes.Major find...
News
- Author:
- Mary Ann Moon
Publish date: August 5, 2014
Key clinical point: If the findings are corroborated in future studies, patients might be tested for genetic mutations in CYP2C genes before they ...
News
- Author:
- Mary Ann Moon
Publish date: August 4, 2014
Key clinical point: Diagnosing and treating those infected with HCV now could nearly eliminate the disease by 2026.
Major finding: The model proje...
News
- Author:
- Mary Ann Moon
Publish date: August 4, 2014
News
- Author:
- Mary Ann Moon
Publish date: August 1, 2014
Key clinical finding: Screening colonoscopy may be more effective based on sex, age, and race and ethnicity.
News
- Author:
- Mary Ann Moon
Publish date: August 1, 2014
News
- Author:
- Mary Ann Moon
Publish date: August 1, 2014
Major finding: Only 19% of the patients with longstanding Crohn’s disease and 11% of those with longstanding ulcerative colitis reported hav...
News
- Author:
- Mary Ann Moon
Publish date: August 1, 2014
Key clinical point: Relatively short interferon-free regimens attain high sustained virologic response rates in HCV type 1b infection.
Major findi...
News
- Author:
- Mary Ann Moon
Publish date: July 30, 2014
Key clinical point: MRI should always be used in the context of the clinical picture when making the diagnosis of MS, and rarer overlap disorders ...
News
- Author:
- Mary Ann Moon
Publish date: July 30, 2014
Key clinical point: Malaria in newly arrived patients from Southeast Asia is likely to be drug resistant.
News
- Author:
- Mary Ann Moon
Publish date: July 30, 2014
Key clinical point: Keep an eye out for new antimalarials in development.Major finding: The median parasite clearance half-life was 0.95 hours for...
News
- Author:
- Mary Ann Moon
Publish date: July 29, 2014
Key clinical point: Patients with advanced lung cancers that have become resistant to erlotinib or gefitinib may benefit from combination therapy ...
News
- Author:
- Mary Ann Moon
Publish date: July 28, 2014
Key clinical point: Tumor stage after completion of neoadjuvant chemotherapy is a much more important predictor of survival than is initial tumor ...
